Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2020
SIETES contiene 93095 citas

 
 
 1 a 20 de 119 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Haugaard JH, Kofoed K, Gislason G, Dreyer L, Egeberg A. Association between drug use and subsequent diagnosis of lupus erythematosus. JAMA Dermatol 2020:2 de septiembre. [Ref.ID 103711]
2.Enlace a cita original Cita con resumen
Wang Y-H, Wintzell V, Ludvigsson JF, Svanström H, Pasterenak B. Association between proton pump inhibitor use and risk of fracture in children. JAMA Pediatrics 2020:1. [Ref.ID 103566]
3. Cita con resumen
Khan MA, Yuan Y, Iqbal U, Kamal S, Khan M, Khan Z, Lee W, Howden CW. No association linking short-term proton pump inhibitor use to dementia: Systematic review and meta-analysis of observational studies. Am J Gastroenterol 2020:2 de enero. [Ref.ID 103525]
4.Enlace a cita original Cita con resumen
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S, COMPASS Investigators. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology 2019;157:agosto. [Ref.ID 103177]
5.Enlace a cita original Cita con resumen
Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf 2019;42:abril. [Ref.ID 103083]
6.Enlace a cita original Cita con resumen
Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol 2019;75:febrero. [Ref.ID 103013]
7. Cita con resumen
Selvanderan SP, Summers MJ, Finnis ME, Plummer MP, Ali Abdelhamid Y, Anderson MB, Chapman MJ, Rayner CK, Deane AM. Pantoprazole or placebo for stress ulcer prophylaxis (POP-UP): randomized double-blind exploratory study. Crit Care Med 2016;44:1842-50. [Ref.ID 100852]
8. Cita con resumen
Anónimo. Comparative effectiveness of proton pump inhibitors. Therapeutics Initiative Evidence Based Drug Therapy 2016;99:1-2. [Ref.ID 100573]
9. Cita con resumen
Dyer O. Physician whistleblower is awarded $59m in Pfizer settlement. BMJ 2016;352:i1195. [Ref.ID 100326]
10.Enlace a cita original Cita con resumen
Begley J, Smith T, Burnett K, Strike P, Azim A, Spake C, Richardson T. Proton pump inhibitor hypomagnasemia - a cause for concern?. Br J Clin Pharmacol 2016;81:753-8. [Ref.ID 100179]
11. Cita con resumen
Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016:14 de abril. [Ref.ID 100161]
12. Cita con resumen
Anónimo. Pfizer settles Medicaid claims for $785 million. DIA Daily 2016:1. [Ref.ID 100000]
13. Cita con resumen
Olsen A-MS, Lindhardsen J, Gislason GH, McGettigan P, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C, Lamberts M. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study. BMJ 2015;351:h5096. [Ref.ID 99631]
14. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
15. Cita con resumen
Anónimo. Consolidations de fracture retardées par des médicaments. Prescrire 2015;35:507-12. [Ref.ID 99440]
16. Cita con resumen
Anónimo. Which PPI?. Med Lett Drugs Ther 2015;57:8-9. [Ref.ID 99216]
17. Cita con resumen
Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, Nead KT, Cooke JP, Leeper NJ. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One 2015:10 de junio. [Ref.ID 99197]
18.Tiene citas relacionadas Cita con resumen
Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Buttò V, Ferrucci L, Bandinelli S, Abbatecola AM, Spazzafumo L, Lattanzio F. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med 2013;173:518-23. [Ref.ID 95257]
19.Enlace a cita original Cita con resumen
Madrilejos R. Inhibidors de la bomba de protons i el balanç risc/benefici. Butlletí d'Informació Terapèutica 2013;24:7-11. [Ref.ID 94629]
20.Enlace a cita original
Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K, on behalf of the Guideline Development Group. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ 2012;344:45-7. [Ref.ID 93219]
Seleccionar todas
 
 1 a 20 de 119 siguiente >>